V
Verantos is the market leader in high-validity real-world evidence across all therapeutic areas in life sciences. By incorporating robust clinical narrative data, artificial-intelligence technology, and measured validity, Verantos is the first company to generate research-grade evidence at scale. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, medical affairs, and regulatory use.
Investor insights
Funding rounds participated in
$1.2M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Software Development
Sectors
Software Development
Date founded
2015
Funding rounds raised
Total raised
$1.2M
from 1 investors over 1 rounds
V
Verantos raised $1.2M on January 20, 2021
Investors: National Science Foundation